RA Capital Management - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.

Quarter-by-quarter ownership
RA Capital Management ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$51,318,000
-9.7%
5,290,4810.0%0.82%
-3.9%
Q1 2021$56,820,000
-27.0%
5,290,4810.0%0.86%
-21.2%
Q4 2020$77,823,000
-11.1%
5,290,481
-14.2%
1.09%
-32.1%
Q3 2020$87,572,000
+75.6%
6,162,6940.0%1.60%
+64.8%
Q2 2020$49,856,000
+94.0%
6,162,694
-3.1%
0.97%
+19.7%
Q1 2020$25,700,0006,361,4460.81%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders